Delivery Order SPE2DB22D2009-SPE2DB23FM4FN
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The firm-fixed-price contract has a ceiling value of $2,159.40 and an ultimate completion date of March 7, 2025. The contract is not designated as a set-aside and represents a discrete procurement under a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, a medication used for influenza treatment and prevention. The delivery order has a ceiling value of $2,716.60 and runs through January 6, 2025. The contract is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza, with a ceiling value of $50,852.35 and a performance period ending on January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order under the Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.99 firm fixed-price contract is for the delivery of 4,566,703,864 units of Oseltamivir Phosphate 75 mg capsules, a medication used for the treatment of influenza. The contract has a performance period through December 13, 2024 and does not...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $6,534.13 and runs through March 19, 2025. It is a firm-fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,964,230 units of the prescription drug Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza. The contract has a total ceiling value of $6,301.50 and a completion date of June 24, 2024. The contract is a firm fixed-price type and does not have...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of oseltamivir phosphate 75 mg capsules. The $1,116.37 firm fixed-price contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,344.25, is for the procurement of 4,565,163,595 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,394,389 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of January 23, 2024 and a ceiling value of $3,630.81. The award is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir Phosphate 75 mg capsules. The $1,318.40 firm fixed price contract does not have a set-aside designation and has an ultimate completion date of July 25, 2024. AmerisourceBergen is delivering the medication under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB23FM4FNDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Oseltamivir Phosphate 75 mg capsules, a medication used for the treatment of influenza. The contract has a ceiling value of $9,461.04 and a completion date of September 20, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 9/19/23 |